Saroglitazar for the treatment of hypertrig-lyceridemia in patients with type 2 diabetes: current evidence.
Diabetes mellitus (DM) is one of the most dreaded metabolic disorders in the world today. It is the leading cause of morbidity and mortality, and plays a cardinal role in quality of life and health economics. DM is associated with a high prevalence of mic..... Read More